Seasonal Influenza Global Clinical Trials Review 2024 Featuring GSK, Novartis, Johnson & Johnson, Novavax, CSL, Sinovac Biotech, Moderna, and Sanofi, Among Others
April 05, 2024 09:29 ET
|
Research and Markets
Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "Seasonal Influenza - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial...
H1 Launches New Solution Empowering Doctors to Find Global Health Opportunities
April 04, 2024 12:00 ET
|
H1
NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- H1, the leading platform for global healthcare data with a database of 10M+ healthcare professional profiles, today announced a new module within its H1...
Glioblastoma Multiforme (GBM) Global Clinical Trials Review 2024, by Region, Country (G7 & E7), Phase, Trial Status, End Points Status and Sponsor Type
April 03, 2024 11:27 ET
|
Research and Markets
Dublin, April 03, 2024 (GLOBE NEWSWIRE) -- The "Glioblastoma Multiforme (GBM) - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical...
Lupus Nephritis Global Clinical Trials Review 2024
April 03, 2024 11:13 ET
|
Research and Markets
Dublin, April 03, 2024 (GLOBE NEWSWIRE) -- The "Lupus Nephritis - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial report...
Molecure has published its financial report for 2023 - the company has significantly accelerated the development of its clinical and pre-clinical programmes and plans to make strong progress in research in 2024 and 2025
April 03, 2024 04:00 ET
|
Molecure
Initiation of Phase II clinical trial of OATD-01 (KITE) for the treatment of pulmonary sarcoidosis following approval from the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare...
Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) Global Clinical Trials Review 2024, Featuring Takeda Pharmaceutical, JCR Pharmaceuticals, GC Corp, RegenxBio, Sangamo Therapeutics and Generium
April 02, 2024 09:48 ET
|
Research and Markets
Dublin, April 02, 2024 (GLOBE NEWSWIRE) -- The "Mucopolysaccharidosis II (Mps II) (Hunter Syndrome ) - Global Clinical Trials Review, 2024" clinical trials has been added to ...
Global AI-based Clinical Trial Solutions Market Projected to Reach $5.65 Billion by 2028
April 01, 2024 18:04 ET
|
Research and Markets
Dublin, April 01, 2024 (GLOBE NEWSWIRE) -- The "AI-based Clinical Trial Solution Providers Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Market Growth...
Clinical Trial Supplies Market Report 2024-2034 - Rising Demand for Biologics Propelling Growth of Cold Chain Distribution Supplies
March 29, 2024 05:20 ET
|
Research and Markets
Dublin, March 29, 2024 (GLOBE NEWSWIRE) -- The "Clinical Trial Supplies Market Report 2024-2034" report has been added to ResearchAndMarkets.com's offering.World revenue for the Clinical Trial...
Global Clinical Trial Supply & Logistics Market for Pharmaceutical Industry Poised for Growth, Reaching USD 6.9 Billion by 2028
March 27, 2024 13:13 ET
|
Research and Markets
Dublin, March 27, 2024 (GLOBE NEWSWIRE) -- The "Global Clinical Trial Supply & Logistics for Pharmaceutical Industry Market (2023-2028) Competitive Analysis, Impact of Economic Slowdown &...
Alterity Therapeutics Receives a A$3.9 Million Research & Development Tax Incentive Refund
March 26, 2024 10:25 ET
|
ALTERITY THERAPEUTICS LIMITED
MELBOURNE, Australia and SAN FRANCISCO, March 27, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company...